Cargando…
Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
BACKGROUND: In type I diabetes mellitus (T1DM) pancreatic β cells are destroyed. Treatment entails exogenous insulin administration and strict diet control, yet optimal glycemic control is hardly attainable. Islet transplant could be an alternative in patients with poor glycemic control, but ineffic...
Autores principales: | Jara, Claudia, Oyarzun-Ampuero, Felipe, Carrión, Flavio, González-Echeverría, Esteban, Cappelli, Claudio, Caviedes, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409404/ https://www.ncbi.nlm.nih.gov/pubmed/32774470 http://dx.doi.org/10.1186/s13098-020-00573-9 |
Ejemplares similares
-
Correction to: Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue
por: Jara, Claudia, et al.
Publicado: (2020) -
Cell microencapsulation with synthetic polymers
por: Olabisi, Ronke M
Publicado: (2015) -
Microencapsulation-based cell therapies
por: Marikar, Safiya Naina, et al.
Publicado: (2022) -
Injectable alginate-microencapsulated canine adipose tissue-derived mesenchymal stem cells for enhanced viable cell retention
por: KOH, Eunji, et al.
Publicado: (2017) -
Natural Biopolymers as Additional Tools for Cell Microencapsulation Applied to Cellular Therapy
por: Cardoso, Liana Monteiro da Fonseca, et al.
Publicado: (2022)